Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

INTRODUCTION: Ascertainment of the pattern and temporal change of biomarkers in preclinical (asymptomatic) sporadic Alzheimer's disease (AD) will increase knowledge about early pathogenesis and facilitate interventional therapeutic trials. METHODS: In this prospective longitudinal study, repeat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Alzheimers Dement (Amst)
Prif Awduron: Stomrud, Erik, Minthon, Lennart, Zetterberg, Henrik, Blennow, Kaj, Hansson, Oskar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2015
Pynciau:
CSF Biomarkers
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879483/
https://ncbi.nlm.nih.gov/pubmed/27239521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.09.002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg